Top Markets
Coin of the day
Hexima Limited Hexima Limited

Hexima Limited

HXL
Rank in Stocks #39776
Hexima Limited is a biotechnology firm focused on the discovery and advancement... Hexima Limited is a biotechnology firm focused on the discovery and advancement of plant-derived proteins and peptides for medical applications in humans. Its primary drug candidate, pezadeftide, a plant defensin, is presently undergoing Phase IIb clinical evaluations in Australia and New Zealand to address fungal toenail infections. The company was established in 1997 and its main operations are situated in Preston, Australia.
Share Price
$0.0084929
Last synced: 2024-11-12
Market Cap
$354.66K
Change (1 day)
-0.64%
Change (1 year)
0.00%
Country
AU
Trade Hexima Limited (HXL)

Category

Number of shares outstanding for Hexima Limited (HXL)
Number of shares outstanding as of August 2026: 0
According to Hexima Limited latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Hexima Limited (HXL) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
253.90M -
US
62.19M -
NL
- -
CH
- -
KR
0.00 -
BE